This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Ward, D. G. et al. Highly sensitive and specific detection of bladder cancer via targeted ultra-deep sequencing of urinary DNA. Eur. Urol. Oncol. https://doi.org/10.1016/j.euo.2022.03.005 (2022)
Li, X. et al. A novel risk score model based on five angiogenesis-related long non-coding RNAs for bladder urothelial carcinoma. Cancer Cell Int. 22, 157 (2022)
Baek, S.-W. et al. YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer. EBioMedicine https://doi.org/10.1016/j.ebiom.2022.104092 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stone, L. Biomarkers for bladder cancer diagnosis, prognosis, monitoring and treatment. Nat Rev Urol 19, 383 (2022). https://doi.org/10.1038/s41585-022-00620-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-022-00620-2